Oczyesa
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for Oczyesa, covering 2025-12-03 to 2026-06-10. Get the full timeline:
Most recent: EMA Authorised: Oczyesa (octreotide hydrochloride) — Camurus AB
2 regulatory and trial events tracked for Oczyesa, covering 2025-12-03 to 2026-06-10. Get the full timeline:
Most recent: EMA Authorised: Oczyesa (octreotide hydrochloride) — Camurus AB